(Q47888732)

6 February 2018

title

Effect of priming with carrier on response to conjugate vaccine (English)

1 reference

6 February 2018

1

D Di John

0 references

author name string

S S Wasserman

2

1 reference

6 February 2018

J R Torres

3

1 reference

6 February 2018

M J Cortesia

4

1 reference

6 February 2018

J Murillo

5

1 reference

6 February 2018

G A Losonsky

6

1 reference

6 February 2018

D A Herrington

7

1 reference

6 February 2018

D Stürcher

8

1 reference

6 February 2018

M M Levine

9

1 reference

6 February 2018

language of work or name

English

0 references

publication date

1 December 1989

1 reference

6 February 2018

number of pages

4

1 reference

inferred from page(s)

published in

The Lancet

1 reference

6 February 2018

volume

2

1 reference

6 February 2018

issue

8677

1 reference

6 February 2018

page(s)

1415-1418

1 reference

6 February 2018

The requirement of more than one antigenic determinant for immunogenicity

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992033-3

7 January 2021

The carrier effect in the secondary response to hapten-protein conjugates. I. Measurement of the effect with transferred cells and objections to the local environment hypothesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992033-3

7 January 2021

Enhanced epitopic response to a synthetic human malarial peptide by preimmunization with tetanus toxoid carrier

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992033-3

7 January 2021

Carrier-priming leads to hapten-specific suppression.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992033-3

7 January 2021

Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992033-3

7 January 2021

Quantitative and qualitative analyses of serum antibodies elicited in adults by Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-tetanus toxoid conjugates

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992033-3

7 January 2021

Vaccination of 18-month-old children with conjugated polyribosyl ribitol phosphate stimulates production of functional antibody to Haemophilus influenzae type b

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992033-3

7 January 2021

EFFECT OF BOVINE GAMMA GLOBULIN ON SUBSEQUENT IMMUNIAZTION WITH DINITROPHENYLATED BOVINE GAMMA GLOBULIN

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992033-3

7 January 2021

Epitopic suppression in synthetic vaccine models: analysis of the effector mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992033-3

7 January 2021

Modulation of carrier-induced epitopic suppression by Bordetella pertussis components and muramyl peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992033-3

7 January 2021

Immunogenicity of synthetic peptides from circumsporozoite protein of Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992033-3

7 January 2021

Rationale for development of a synthetic vaccine against plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992033-3

7 January 2021

Effect of carrier selection on immunogenicity of protein conjugate vaccines against Plasmodium falciparum circumsporozoites

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992033-3

7 January 2021

10.1016/S0140-6736(89)92033-3

Identifiers

DOI

1 reference

6 February 2018

1 reference

6 February 2018